🏛️ Verified NIH Record • Updated 2025-12-11
Myocardial Inflammation in Systemic Lupus Erythematosus (NCT01761422)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Stacy Ardoin MD
🩺 Plain-English Summary (8th-Grade Level)
The goal is to assess for myocardial edema on cardiac MRI during SLE flare to assess for myocardial inflammation.
Who can join: Review the eligibility criteria below.
Location: Stacy Payne Ardoin — Columbus, Ohio
Age range: 18 Years to 60 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stacy Payne Ardoin — Columbus, Ohio
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in SLE
- Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus — Anniston, Alabama
- UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients — Charleston, South Carolina
- CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus — Philadelphia, Pennsylvania
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus — Avondale, Arizona
Explore by condition: All SLE clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.